- July 12, 2019
- Brain Injury
- Personal Injury
Unfortunately, current concussion testing methods do not always achieve the crucial goal of early detection. The process of identifying a concussion often begins by evaluating the apparent symptoms and any changes in brain function — but the signs of a mild TBI do not always appear right away. In some cases, it can take days or weeks for symptoms of a concussion to appear following the initial injury. This leaves many patients untreated for a significant period of time, and can contribute to a greater negative impact.
A new type of concussion testing aims to reduce the number of undetected concussions by using a device that can accurately identify a mild TBI much sooner than traditional methods. Instead of relying on a physical examination or digital imaging, the device analyzes the blood of patients to test for signs of a concussion.
The Food and Drug Administration (FDA) entered the new concussion test into the Breakthrough Devices Program, “which fast-tracks the development, testing and approval of new devices that have the potential to change medical care for life-threatening or debilitating conditions,” says ABC News.
A traumatic brain injury can cause detrimental effects to brain functionality if left untreated. Even a mild concussion can contribute to long-term effects on the brain if it is not promptly addressed. The use of a blood test that can accurately detect a concussion quickly following an injury will lead to more rapid treatment, and therefore, a minimization of long-term effects.
Did you or a loved one sustain a brain injury caused by the negligence of another person? If so, you may be eligible to receive compensation. Contact Goodman Acker P.C. to discover your options.
For a free consultation with our experienced legal team, call (248) 286-8100 or send us your contact information.